Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics
Advanced Science · 2025
DOI: 10.1002/advs.202417283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Wenxin Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health Sciences, Hainan Province Key Laboratory of One Health, Collaborative Innovation Center of One Health, Hainan University, H…. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Microplastics, Gastrointestinal Tract. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province, Hainan Province Science and Technology Special Fund.
Abstract (Originalsprache)
Micro‐ and nanoplastics, particularly those derived from food‐contact materials like polyethylene terephthalate (PET), can damage gut barriers, making the gastrointestinal system more vulnerable to inflammation and infections. Here, a probiotic‐based drug delivery system (EcN T @L) is devised to mitigate nanoplastics‐induced gut barrier dysfunction by modulating gut immunity and microbiota. Escherichia coli Nissle 1917 (EcN) is genetically engineered to produce transforming growth factor‐β (TGF‐β) and then modified with an Eudragit L100‐55 coating. This engineered probiotic acts as an in vivo “drug factory”, exerting anti‐inflammatory and immune‐regulatory effects, with improved retention and bioavailability in the gastrointestinal tract. EcN T @L effectively protects Caco‐2 cells from inflammation and infections induced by nano PET, primarily by activating the NF‐κB signaling pathway. Besides, EcN T @L demonstrates superior in vivo therapeutic efficacy in treating gastrointestinal infection caused by the combined presence of nano PET and Salmonella , outperforming commercial antibiotics due to its ability to modulate immune responses and gut microbiota. This study highlights the potential of probiotic‐based drug delivery systems in addressing nanoplastics‐induced gut dysfunctions, offering a promising strategy for mitigating the environmental impact of micro‐ and nanoplastics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life and Health Sciences, Hainan Province Key Laboratory of One Health, Collaborative Innovation Center of One Health, Hainan University, Haikou, 570228, China.
- State Key Laboratory of Microbial Technology, Shandong University, Jinan, 250100, China.
- Faculty of Animal Science and Technology, Key Laboratory of Animal Nutrition and Feed Science of Yunnan Province, Yunnan Agricultural University, Kunming, 650201, China.
- School of Chemistry and Chemical Engineering, Hainan University, Haikou, 570228, China.
ORCID-Profile: Yong Liu, Juanjuan Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
- Hainan Province Science and Technology Special Fund
Zitieren
APA
Chen, W., Guo, Q., Li, H., Chi, X., Ma, X., Tang, Y., Liang, Q., Liu, Z., Liu, Y., & Li, J. (2025). Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics. Advanced Science. https://doi.org/10.1002/advs.202417283
Vancouver
Chen W, Guo Q, Li H, Chi X, Ma X, Tang Y, et al. Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics. Advanced Science. 2025. doi:10.1002/advs.202417283
BibTeX
@article{Chen2025,
author = {Chen, Wenxin and Guo, Qiyan and Li, Hong and Chi, Xue and Ma, Xiang and Tang, Yanqiong and Liang, Quanfeng and Liu, Zhu and Liu, Yong and Li, Juanjuan},
title = {Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202417283}
}
EUVIMED